This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ontario Institute for Cancer Research, University Health Network. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 14 
1 out of 312 
Years Active: 2025
Title: Shadrielle Melijah G Espiritu: Innovator in Cancer Research
Introduction
Shadrielle Melijah G Espiritu is a notable inventor based in Kitchener, Canada. He has made significant contributions to the field of cancer research, particularly in the area of tumor clonality and its implications for cancer diagnosis and prognosis. His innovative approach aims to enhance the understanding of cancer evolution and patient outcomes.
Latest Patents
Shadrielle holds a patent titled "Cancer risk based on tumour clonality." This patent outlines a method for diagnosing or prognosing a subject with cancer. The method involves providing cancer DNA sequencing data from a cancer sample, comparing it with control DNA sequencing data to identify genetic aberrations, and determining the clonal and subclonal populations present in the sample. Furthermore, it includes constructing a phylogenetic map of these populations and assigning a risk level to the subject based on their genetic profile. This innovative method aims to correlate the level of evolution and the number of subclonal populations with patient outcomes and responses to therapy.
Career Highlights
Throughout his career, Shadrielle has worked with esteemed organizations such as the Ontario Institute for Cancer Research and the University Health Network. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Shadrielle has had the opportunity to work alongside notable colleagues, including Yiyang Liu and Paul Boutros. These collaborations have further enriched his research and have played a crucial role in advancing the understanding of cancer biology.
Conclusion
Shadrielle Melijah G Espiritu is a pioneering inventor whose work in cancer research is making a significant impact on the field. His innovative methods for assessing cancer risk based on tumor clonality are paving the way for improved diagnostic and prognostic tools for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile